Healthcare Global Enterprises is currently trading at Rs 749.65 on the BSE, up by 1.00 point or 0.13% from its previous close of Rs 748.65.

The stock opened at Rs 740.00 and touched a high of Rs 748.70 and a low of Rs 726.60. A total of 18,850 shares have been traded so far.

The BSE Group ‘A’ stock, with a face value of Rs 10, recorded a 52-week high of Rs 804.30 on 29-Oct-2025 and a 52-week low of Rs 455.75 on 13-Nov-2024.

During the past week, the stock registered a high of Rs 769.15 and a low of Rs 726.60. The company’s current market capitalization stands at Rs 10,434.01 crore.

Promoters hold 63.78% stake in the company, while Institutions and Non-Institutions hold 21.95% and 14.27% respectively.

Healthcare Global Enterprises has received approval to invest up to Rs 110 crore in HCG Kolkata Cancer Care LLP, Rs 15 crore in HCG Oncology Hospitals LLP, and Rs 25 crore in HCG NCHRI Oncology LLP—its wholly owned subsidiaries. These investments will be used primarily for repayment of dues, working capital, and general corporate purposes. The investment process will be completed on or before March 31, 2026.

The Board of Directors approved the proposal at its meeting held on November 12, 2025.

Healthcare Global Enterprises (HCG), headquartered in Bengaluru, is a specialty healthcare provider in India focused on cancer and fertility services. It operates the largest private cancer care network in the country and also runs fertility centres under the ‘Milann’ brand.